// App-Quantinova.ai

226 : Analytical platform development for standardisation and quality control of major grass allergen content ‐ Lol p1 in grass allergoid vaccine

Researchers

Presenter

  • Starchenka S

Principal Investigators

  • Wilson TD

  • Knox KL

  • Visic P

  • Kuklinska-Pijanka AM

  • Hewings SJ

  • Heath

  • Bermingham M

  • Skinner MA

Medical Centers

  • Allergy Therapeutics Ltd, Worthing, United Kingdom

  • INDOOR Biotechnologies, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Collagen type IV alpha 2 chain

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved